spironolactone has been researched along with Complication, Intraoperative in 3 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum potassium concentration should be measured immediately before operation to detect hyperkalemia in heart failure patients treated with spironolactone." | 7.71 | Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency. ( Carpenter, JP; Cheung, AT; Hu, Y, 2002) |
| "Serum potassium concentration should be measured immediately before operation to detect hyperkalemia in heart failure patients treated with spironolactone." | 3.71 | Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency. ( Carpenter, JP; Cheung, AT; Hu, Y, 2002) |
| "Treatment of primary aldosteronism (PA) aims at preventing or correcting hypertension, hypokalemia and target organ damage." | 1.43 | SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery. ( Amar, L; Chaffanjon, P; Kraimps, JL; Ménégaux, F; Steichen, O; Zinzindohoue, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steichen, O | 1 |
| Amar, L | 1 |
| Chaffanjon, P | 1 |
| Kraimps, JL | 1 |
| Ménégaux, F | 1 |
| Zinzindohoue, F | 1 |
| Pandia, MP | 1 |
| Bithal, PK | 1 |
| Gupta, M | 1 |
| Hu, Y | 1 |
| Carpenter, JP | 1 |
| Cheung, AT | 1 |
3 other studies available for spironolactone and Complication, Intraoperative
| Article | Year |
|---|---|
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery.
Topics: Adrenalectomy; France; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Intraoperative Complic | 2016 |
Life-threatening hyperkalemia in the intraoperative period.
Topics: Brain Neoplasms; Decompression, Surgical; Diabetes Complications; Diuretics; Glioma; Humans; Hyperka | 2004 |
Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency.
Topics: Aged; Aortic Aneurysm, Abdominal; Blood Gas Analysis; Heart Failure; Humans; Hyperkalemia; Intraoper | 2002 |